Govt Delays Advanced Medicines Launch in Pakistan – Patients Face Treatment Crisis 2026
Govt Delays Advanced Medicines Launch in Pakistan – Patients Face Treatment Crisis 2026
The Government of Pakistan is facing criticism after delaying the approval of prices for advanced life-saving medicines. These delays have stopped the launch of new treatments for serious diseases like cancer, heart disease, and hypertension in Pakistan.
In this article, we explain everything in easy English, including reasons for delay, impact on patients, DRAP role, and future outlook.
Overview of Medicine Approval Delay in Pakistan
For more than six months, the government has not approved pricing notifications for many new medicines.
Key Facts:
- 60–70 medicines waiting for approval
- Includes life-saving drugs
- Patients unable to access modern treatments
What is the Issue?
The main issue is:
👉 Delay in price approval by the government
Without price approval, companies cannot launch medicines in Pakistan.
Role of Drug Regulatory Authority of Pakistan
DRAP is responsible for:
- Evaluating medicines
- Approving safety and quality
- Recommending prices
However, final approval is done by the federal cabinet.
Why Are Medicines Not Available?
Even though DRAP has completed many processes:
- Pricing committee has reviewed medicines
- Recommendations are ready
👉 But final approval from the cabinet is still pending.
Diseases Affected by Delay
The delayed medicines are used for:
🧬 Cancer Treatment
Advanced therapies not available
❤️ Heart Diseases
New drugs delayed
💊 Hypertension
Modern medicines missing
Impact on Patients
😟 Serious Consequences:
- Delayed treatment
- Increased health risks
- Higher mortality rate
Patients are forced to wait or seek alternatives.
Risk of Smuggled Medicines
Experts warn:
- Illegal medicines may enter market
- Quality may be unsafe
- Health risks increase
What Experts Say
According to Tauqeer Ul Haq (PPMA):
- Issue is only about price approval
- Not related to price increase
- Government confusion may be cause
Role of Federal Cabinet
The federal cabinet, led by
Shehbaz Sharif
is responsible for final approval.
Despite multiple meetings, no decision has been made.
Why Price Approval is Important
Price approval ensures:
- Medicines are affordable
- Companies can sell legally
- Market remains stable
Pharmaceutical Industry Concerns
Pharmaceutical companies are facing:
- Delayed product launch
- Financial losses
- Increased backlog
Impact on Healthcare System
🏥 Negative Effects:
- Outdated treatments
- Limited options for doctors
- Increased burden on hospitals
Government’s Responsibility
The Government of Pakistan must:
- Approve prices quickly
- Ensure medicine availability
- Protect public health
Possible Reasons for Delay
⚠️ Confusion Between:
- New medicine pricing
- Existing medicine price increase
⚠️ Policy Challenges
⚠️ Administrative delays
Future Outlook
Experts suggest:
- Faster approval process
- Clear policies
- Digital system implementation
Popular Google Search Keywords (Included)
- medicine shortage Pakistan 2026
- DRAP approval delay Pakistan
- new medicines Pakistan availability
- cancer medicine Pakistan delay
- pharmaceutical policy Pakistan
Conclusion
The delay in approval of advanced medicines is a serious issue. It is affecting patients, doctors, and the entire healthcare system.
The Government of Pakistan must act quickly to resolve this issue and ensure access to modern treatments.
